A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy

Currently the main treatment of acute myeloid leukemia (AML) is chemotherapy combining hematopoietic stem cell transplantation. However, the unbearable side effect of chemotherapy and the high risk of life-threatening infections and disease relapse following hematopoietic stem cell transplantation r...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Luchen, Yang, Nanfei, Chen, Bing, Bei, Yuncheng, Kang, Zisheng, Zhang, Can, Zhang, Nan, Xu, Peipei, Yang, Wei, Wei, Jia, Ke, Jiangqiong, Sun, Weijian, Li, Xiaokun, Shen, Pingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372914/
https://www.ncbi.nlm.nih.gov/pubmed/37521858
http://dx.doi.org/10.1016/j.apsb.2023.05.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372914/
https://www.ncbi.nlm.nih.gov/pubmed/37521858
http://dx.doi.org/10.1016/j.apsb.2023.05.007

Ejemplares similares